Probuphine Approval Status

  • FDA approved: No
  • Brand name: Probuphine
  • Generic name: buprenorphine
  • Company: Titan Pharmaceuticals, Inc.
  • Treatment for: Opiate Dependence

Probuphine (buprenorphine) is an opioid partial agonist subdermal implant in development for the treatment of opioid dependence.

FDA Approval Status for Probuphine

DateArticle
May  1, 2013Titan Pharmaceuticals Receives Complete Response Letter From the FDA for Probuphine New Drug Application
Feb 27, 2013Titan Pharmaceuticals Announces Date of FDA Advisory Committee Review of Probuphine for the Treatment of Opioid Dependence
Oct 29, 2012Titan Pharmaceuticals Announces Submission of New Drug Application for Probuphine for the Treatment of Opioid Dependence

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)